Document is current
Any future updates will be listed below
-
Authors
Horcajada, Juan P.
Aldonza, Rebeca
Real, Mónica
Castañeda-Espinosa, Silvia
Sendra, Elena
Gomez-Junyent, Joan
López-Montesinos, Inmaculada
Gómez-Zorrilla, Silvia
Briansó, Silvia
Duran-Taberna, Montserrat
Fernández, Andrés
Tarragó, Cristina
Auguet-Quintillá, Teresa
,
Arenas-Miras, Maria
Arrieta‐Aldea, Itziar
Cañas-Ruano, Esperanza
Güerri‐Fernandez, Roberto
Knobel, Hernando
Montero, Maria Milagro
Pelegrín, Ivan
Sánchez‐Martínez, Francisca
Sorlí, Luisa
Villar‐García, Judith
,
Alibalic, Ajla
Camaron, Javier
Febrer, Anna Maria
Bertran, Laia
Barrientos, Andrea
-
Funding
Funding for this research was provided by:
Ferrer Internacional, S.A.
- License Information
-
More Information
Article History
Received: 20 August 2023
Accepted: 11 December 2023
First Online: 25 February 2024
Declarations
:
: The competing Ethics Committee of Hospital del Mar, Barcelona, Spain, approved the study protocol on 31<sup>st</sup> of July 2020.
: JPH has received consulting fees from Gilead, Menarini and TFF Pharmaceuticals, and participated in educational activities from MSD, Pfizer and Angelini. All other authors have no conflicts of interests.
